SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,921,183 | -12.7% | 1,991,817 | +25.9% | 1.82% | -15.9% |
| Q2 2023 | $33,117,351 | +45.8% | 1,582,291 | +47.1% | 2.17% | +49.3% |
| Q1 2023 | $22,712,955 | +26.9% | 1,075,424 | +53.0% | 1.45% | +36.8% |
| Q4 2022 | $17,893,233 | +41.8% | 703,074 | +33.9% | 1.06% | +44.7% |
| Q3 2022 | $12,616,000 | +58.6% | 525,002 | +27.0% | 0.73% | +10.9% |
| Q2 2022 | $7,954,000 | -36.2% | 413,428 | -42.3% | 0.66% | -30.0% |
| Q1 2022 | $12,463,000 | -40.1% | 717,064 | -24.6% | 0.95% | -22.2% |
| Q4 2021 | $20,822,000 | +163.3% | 951,226 | +129.9% | 1.22% | +159.8% |
| Q3 2021 | $7,909,000 | +18.4% | 413,841 | +38.6% | 0.47% | +16.7% |
| Q1 2021 | $6,678,000 | -19.5% | 298,644 | -19.9% | 0.40% | -18.8% |
| Q4 2020 | $8,293,000 | +508.4% | 372,909 | +305.5% | 0.49% | +474.4% |
| Q2 2020 | $1,363,000 | -25.0% | 91,964 | -62.2% | 0.09% | -47.6% |
| Q3 2019 | $1,817,000 | -19.6% | 243,150 | +0.2% | 0.16% | -21.2% |
| Q2 2019 | $2,260,000 | +101.6% | 242,729 | +13.8% | 0.21% | +92.6% |
| Q1 2019 | $1,121,000 | -28.0% | 213,359 | -39.1% | 0.11% | -44.3% |
| Q4 2018 | $1,558,000 | +11.4% | 350,110 | +102.2% | 0.19% | +55.2% |
| Q3 2018 | $1,398,000 | +79.2% | 173,112 | +56.0% | 0.12% | +150.0% |
| Q2 2018 | $780,000 | +350.9% | 110,967 | +815.3% | 0.05% | +66.7% |
| Q1 2018 | $173,000 | – | 12,124 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |